ScholarIQanswers from OpenAlex

2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial)

PaperCitations, authors & open-access status

2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial) is a paper indexed in ScholarIQ from OpenAlex.

How many citations does 2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial) have?

ScholarIQcitation count

2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial) has 0 citations in the OpenAlex counts ScholarIQ stores.

When was 2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial) published?

ScholarIQyear

2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial) has 2022 year in the ScholarIQ index.

What is the open-access status of 2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial)?

ScholarIQoa status

2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial) has bronze oa status in the ScholarIQ index.

What is the DOI of 2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial)?

ScholarIQdoi

The DOI for 2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial) is on the source record.

What is the OpenAlex record for 2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial)?

ScholarIQopenalex

The OpenAlex for 2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial) is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial